Navigation Links
US Oncology Network Recruits 1,000th Patient to Phase I Oncology Trials
Date:10/12/2010

THE WOODLANDS, Texas, Oct. 12 /PRNewswire/ -- US Oncology, Inc., the nation's leading integrated oncology company, announced today that it has enrolled the 1,000th patient in a Phase I clinical trial through its US Oncology Research Network. Phase I clinical trials present special challenges, including increased safety concerns, higher variability of patient disease, more complex trial designs, and some first-in-human trials, making Phase I trials more difficult to operate in the community setting.

(Logo: http://photos.prnewswire.com/prnh/20100517/DA06089LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20100517/DA06089LOGO)

The US Oncology Research team has been helping investigators conduct new agent Phase I trials in community-based oncology since 2005. The US Oncology team running the trials – referred to as the Translational Oncology Program (TOP), is chaired by Daniel Von Hoff, M.D., chief scientific officer for US Oncology and physician-in-chief for the Translational Genomics Institute (TGen) based out of Scottsdale, Ariz. TOP is a select group of physicians affiliated with the US Oncology Research Network that participate in Phase I research studies. This experience gives the physicians and their community-based practices a leadership role in the testing of new cancer therapies to provide novel therapeutic modalities for treatment and support to patients as early as possible. The TOP program also provides physicians and nurses experience with the agents early on in their development proc
'/>"/>

SOURCE US Oncology, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. US Oncology Appoints Stephen Smith Vice President/General Manager Research and Personalized Science Services
2. MD Anderson Becomes a GeneGo Center of Excellence Using MetaCore for Oncology Research
3. US Oncology Pharmaceutical Distribution Service Wins National Safety Council Award
4. Expression Genetics EGEN-001 Named One of 10 Most Promising Oncology Products by Windhover
5. OncologySTAT Advisors Name Years Top Developments in Cancer Treatment and Research
6. First Coast Oncology to Offer Next Generation Proton Therapy
7. Radiation Therapy Oncology Group and US Oncology Enter Collaboration to Increase Patient Access to National Clinical Trials
8. Onyx Pharmaceuticals Licenses Rights to Novel Targeted Oncology Agent From BTG International
9. Debiopharm and Aurigene Sign Licensing Agreement for the Development and Commercialisation of Debio 0617, a Novel Inhibitor of an Undisclosed Oncology Pathway
10. Varian Medical Systems Introducing OncoView(TM) - an Oncology Specific Image Management and Storage Solution
11. Spectrum Pharmaceuticals and Cell Therapeutics to Jointly Market ZEVALIN, a Proprietary, Marketed Oncology Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... , Aug. 21, 2014 OTC ... Pharmaceuticals Inc., a biotechnology company, on its approval ... previously traded on OTCQX®, the best marketplace for ... Markets Group. Logo - http://photos.prnewswire.com/prnh/20110118/MM31963LOGO ... the successful execution of its growth strategy and ...
(Date:8/21/2014)... 21, 2014 Ontotext S4 , ... Ontotext . Now the same enterprise hardened ... structured and unstructured data is available to start-ups and ... enterprise technology. Organizations that do not have resources to ... can use S4 since there is no need for ...
(Date:8/20/2014)... Clintrax Global, Inc., a worldwide provider ... Raleigh, NC , recently announced the addition ... of Administration. As Vice President ... including their alignment with company objectives and policies.  ... an HR executive, specializing in needs assessments, customer ...
(Date:8/20/2014)... , Aug. 20, 2014 Neurotrope, ... host a conference call to provide an update ... p.m. Eastern daylight timeDial-in numbers:(888) 505-4369 (U.S. and ... Live web cast: www.neurotropebioscience.com , under "Investor Relations"The ... after completion through September 2, 2014 at (888) ...
Breaking Biology Technology:OTC Markets Group Congratulates Immune Pharmaceuticals on NASDAQ Listing 2Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 2Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 3Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 4Clintrax Global, Inc. Announces Addition to Executive Team 2Neurotrope To Host Conference Call 2
... Aug. 25 In celebration of a seminal discovery in ... the Philadelphia Chromosome Symposium: Past, Present and Future , ... at The Chemical Heritage Foundation, 315 Chestnut Street, Philadelphia.  The ... first genetic abnormality associated with cancer, and the first to ...
... Scientists and engineers seek to meet three goals ... such as microalgae: efficiency, economical production and ecological ... of biomedical and chemical engineering in the L.C. ... SU chemical engineering Ph.D. student Satvik Wani have ...
... Inc. ("Dyadic") (Pink Sheets: DYAI ), ... development, manufacture and sale of specialty enzyme products ... biopharmaceutical industries, today announced that it has completed ... secured promissory notes (the "Notes") with two investors. ...
Cached Biology Technology:Fox Chase Celebrates the 50th Anniversary of the Discovery of the Philadelphia Chromosome 2Fox Chase Celebrates the 50th Anniversary of the Discovery of the Philadelphia Chromosome 3Fox Chase Celebrates the 50th Anniversary of the Discovery of the Philadelphia Chromosome 4SU research team uses nanobiotechnology-manipulated light particles to accelerate algae growth 2Dyadic International Raises $3 Million in Private Placement of Convertible Notes 2
(Date:8/20/2014)... /CNW/ -  Issue Serious allergic reactions ... life threatening for some children.    What you ... have food allergies and this number may be increasing, especially ... estimated to have food allergies.  The symptoms ... hives to breathing difficulties and loss of consciousness. Symptoms can ...
(Date:8/20/2014)... Oklahoma Medical Research Foundation a five-year, $14.5 million grant ... effects on humans. , For 10 years, OMRF ... the human immune response to anthrax bacteria as part ... funding came soon after anthrax-laced letters killed five and ... of Sept. 11, 2001. , The long-term goal ...
(Date:8/20/2014)... past few years, Virginia Tech,s Wu Feng has built ... from the "Computing in the Cloud" program, and synergistically ... million award from the Air Force on "big computing" ... and the National Institutes of Health on "big data" ... the "parallel computing" aspects from each grant, he was ...
Breaking Biology News(10 mins):Information Update - Allergens and food safety at school - What's in your child's lunch? 2Information Update - Allergens and food safety at school - What's in your child's lunch? 3$14.5 million grant awarded to continue anthrax studies 2The internet was delivered to the masses; parallel computing is not far behind 2The internet was delivered to the masses; parallel computing is not far behind 3The internet was delivered to the masses; parallel computing is not far behind 4
... analysis has found that both real and sham acupuncture treatments ... treat breast cancer. Published early online in CANCER , ... may help clinicians improve care for cancer patients. The results ... inert or may, like real acupuncture, have beneficial effects. ...
... new malaria treatments by identifying a way to stop malaria ... Chemistry , they show that blocking the activity of an ... mice from showing symptoms and extends their lifespan. The team ... and hope to start clinical trials of potential treatments within ...
... scientists have assumed that if mercury is high and increasing ... same is true of fish elsewhere in the Arctic. ... Canada has discovered that assumption is wrong in much of ... processes as a result of diverse atmospheric, geological, and biological ...
Cached Biology News:Breast cancer patients experience fewer side effects from anticancer drug when receiving acupuncture 2Malaria drug target raises hopes for new treatments 2Virginia Tech research overturns assumption about mercury in the Arctic 2Virginia Tech research overturns assumption about mercury in the Arctic 3
Rabbit polyclonal to Phosphothreonine-Proline / Phosphoserine-Proline ( Abpromise for all tested applications)....
Mouse monoclonal [7C6] to Bcr-abl ( Abpromise for all tested applications). SwissProtID: P11274...
Chicken polyclonal to Thioredoxin domain containing 9 ( Abpromise for all tested applications). Antigen: Full length protein (Human) Entrez Gene ID: 10190 Swiss Protein ID: O14530...
Mouse anti-IkBa/MAD-3 Class: Antibody Product Group: Signalling molecules and phospho-specific Antibody...
Biology Products: